Connect with us

Press Release

Horizon Copper CEO Discusses Strategic Portfolio Expansion and Future Plans

Published

on

–News Direct–

Horizon Copper CEO Erfan Kazemi joined Steve Darling from Proactive to share insights into the company's robust portfolio and strategic future plans, emphasizing a focus on copper assets. Horizon Copper is dedicated to building a strong portfolio of copper projects. The company currently holds interests in three major copper assets. One of their notable investments includes a 1.7% stake in the Antamina mine, which is the third-largest copper mine globally. This asset is not only generating cash flow but also recently had its mine life extended by over a decade. The approval of Antamina's Environmental Impact Assessment (EIA) could potentially further boost its cash flow. Another significant asset in Horizon Copper's portfolio is its interest in the Oyu Tolgoi mine, which is anticipated to become the fourth-largest copper mine in the world. This project is expected to start generating cash flow by 2027, with long-term production forecasts spanning several decades. Horizon Copper's third key asset is the Hod Maden project, which is notable for its discovery and is expected to enter commercial production within a few years. Kazemi emphasized Horizon Copper's strategy of partnering with large, reputable companies like Rio Tinto to diversify and expand their portfolio continuously. The company is also actively seeking new acquisitions to ensure steady, long-term returns for its shareholders.

Contact Details

Proactive North America

+1 604-688-8158

na-editorial@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/horizon-copper-ceo-discusses-strategic-portfolio-expansion-and-future-plans-475477516

Horizon Copper Corp

comtex tracking

COMTEX_453490438/2655/2024-06-07T12:08:44

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

ENCLONY Expands Automated Visual Inspection Tech as Pharmaceutical Production Speeds Accelerate

Published

on

Machine vision technology ensures 100% surface inspection and zero-blind-spot quality control for tablets and capsules.

Seoul, South Korea, 15th Oct 2026  – As pharmaceutical manufacturing processes become increasingly automated and production speeds rise, automated visual inspection (AVI) is becoming essential for ensuring the quality of tablets and capsules.

Visual inspection in pharmaceutical production goes beyond checking product appearance. During manufacturing, tablets and capsules can develop various defects, including chipping, cracks, foreign matter, discoloration, coating irregularities, and printing errors. Detecting these defects before shipment and selecting only compliant products is a vital step in pharmaceutical quality management.

Above all, this process is crucial for patient safety. Broken or chipped tablets and capsules with compromised contents do not represent acceptable product quality. Foreign matter or contamination poses severe hygiene and safety concerns, while cracked or peeling coatings can directly impact drug efficacy. For enteric-coated or sustained-release formulations designed to control the release site and rate of active ingredients, coating integrity is directly linked to product function. Defective coating may cause active ingredients to release too quickly or too slowly, affecting both safety and therapeutic outcomes. Therefore, visual inspection is a necessary quality assurance process to ensure patients receive medications that meet intended performance standards.

From a manufacturer’s perspective, consistent quality builds corporate and brand trust. Pharmaceutical companies exporting to international markets must stably meet quality standards across different regions. Defective products reaching the market can cause customer complaints, costly recalls, returns, and loss of business trust, making pre-shipment screening vital.

ENCLONY Co., Ltd., a specialist in automated pharmaceutical inspection systems, utilizes machine vision technology that captures and analyzes the entire surface of tablets and capsules from multiple angles. The system inspects top, bottom, and side surfaces of tablets, as well as the cylindrical body and ends of capsules, eliminating blind spots to identify defects such as chipping, contamination, discoloration, and coating or printing flaws.

Using algorithms that step-by-step learn normal product characteristics, ENCLONY sets inspection criteria tailored to each product. To prevent defect-identified items from mixing into compliant batches, the company applies a patented Triple Checking System. This technology re-verifies the removal of rejected items after sorting, ensuring defective products are reliably separated.

In terms of throughput, ENCLONY’s PLANET EV model can inspect up to 425,000 tablets per hour, while the high-speed PLANET EVS model processes up to 600,000 tablets per hour, enabling complete, 100% inspection even in high-volume production environments.

“For pharmaceutical companies, consistent quality is a key factor in building corporate trust, and for patients, it directly impacts receiving safe, reliable medications,” stated Kyung-Ho Lee, CEO of ENCLONY. “As production speeds increase, the importance of automated visual inspection technology that can evaluate every item against identical standards will continue to grow.”

Lee added, “ENCLONY plans to continuously advance its machine vision and automated inspection technologies to stably inspect full product surfaces and accurately sort defects, even in high-speed manufacturing environments.”

ENCLONY develops and supplies comprehensive automated inspection solutions for pharmaceutical manufacturing, including automated visual inspection systems for tablets and capsules, integrated laser printing and inspection systems, and containment inspection systems for high-potency active pharmaceutical ingredients (HPAPIs).

[About ENCLONY Co., Ltd.] ENCLONY Co., Ltd. is a South Korea-based technology leader specializing in automated visual inspection and laser printing systems for the pharmaceutical manufacturing industry.

For more information, please visit http://www.enclony.com

Media Contact

Organization: ENCLONY Co., Ltd.

Contact Person: Young-Mi Cho

Website: http://www.enclony.com

Email: Send Email

City: Seoul

Country: South Korea

Release id: 49942

View source version on King Newswire:
ENCLONY Expands Automated Visual Inspection Tech as Pharmaceutical Production Speeds Accelerate

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Medspa Marketing Agency for USA Reports 200% Growth in 2026 and Opens in New York

Published

on

Medspa Marketing Agency for USA has reported 200% growth in 2026, reflecting increased demand from medical spas seeking specialist support with their marketing and online visibility.

NEW YORK, NY — October 12, 2026 — Medspa Marketing Agency for USA has reported 200% growth in 2026, reflecting increased demand from medical spas seeking specialist support with their marketing and online visibility.

Based at 222 E 41st St, New York, NY 10017, the agency works with med spas across the United States. Its services help businesses present their treatments clearly online, reach prospective patients and create a more consistent path from initial enquiry to consultation.

The agency says its growth reflects the need for focused marketing in a competitive sector where prospective patients often compare providers, services and reviews before making contact.

“Medical spas need to make it easy for people to understand what they offer and take the next step,” said a spokesperson for Medspa Marketing Guys and Agency for USA. “We’re pleased to see more businesses looking for marketing support tailored to the needs of the med spa industry.”

Medspa Marketing Agency for USA supports medical spas with digital marketing designed around their services and business goals. The agency works with clients seeking to improve their visibility, communicate treatment information and generate enquiries from people interested in med spa services. Found at Medspa Marketing Agency for USA, 222 E 41st St, New York, NY 10017, United States, Phone: 07583 774098

The 200% growth reported in 2026 marks a significant year for the agency as it continues to serve med spas across the country. Businesses interested in learning more about its services can contact the agency directly.

About Medspa Marketing Agency for USA

Medspa Marketing Agency for USA provides marketing services for medical spas throughout the United States.

Media Contact

Organization: Med Spa Marketing Guys

Contact Person: Cormac Reynolds

Website: https://medspamarketingguys.com/

Email: Send Email

City: New York

State: New York

Country: United States

Release id: 49888

View source version on King Newswire:
Medspa Marketing Agency for USA Reports 200% Growth in 2026 and Opens in New York

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Anabei Addresses Furniture Reviews With Machine-Washable System for Families

Published

on

Anabei, a direct-to-consumer furniture brand based in Rancho Cordova, California, is drawing attention from families seeking durable, washable seating solutions. The brand’s fully machine-washable, modular sofa system is designed to address the practical maintenance demands that conventional upholstered furniture cannot meet in active households with children.

United States, 15th Oct 2026 – Anabei, a direct-to-consumer furniture brand operating under parent company CABA Design, offers a machine-washable modular sofa system built around the specific maintenance needs of growing families. As household demand for durable, easy-care furniture increases, Anabei furniture reviews from family buyers reflect a consistent account of the brand’s washable design holding up to the sustained, high-frequency use that children introduce into a living space.

Anabei Addresses Furniture Reviews With Machine-Washable System for Families

Conventional upholstered furniture presents a recurring challenge for families with young children: fabrics absorb spills, stains accumulate between professional cleaning appointments, and the cost and logistics of maintaining non-washable upholstery compounds over years of daily use. Anabei’s system is engineered to remove that maintenance burden at the source. The brand’s removable covers, spanning both cushions and the frame, are fully machine-washable, allowing families to clean their furniture through a standard laundry cycle rather than a scheduled cleaning service. The covers are constructed from PFC-free, Oeko-Tex Standard 100 certified performance fabrics that provide liquid and stain resistance at the fiber level, offering passive protection between washing cycles without the use C6 or C8 chemicals. 

The structural foundation of Anabei’s machine-washable sofa collection is a powder-coated steel frame designed to hold its form under the sustained, high-occupancy use common in family households. The frame does not compress or shift over time, which means the fitted covers that sit over it continue to seat correctly as the furniture ages. This dimensional stability is a deliberate construction choice, one that extends the functional life of the sofa beyond what softer framing materials typically deliver in environments with children.

Anabei’s modular design addresses a secondary challenge for growing families: furniture that fits the household as it is today may not fit the household three or four years from now. The brand’s modular system allows families to start with a configuration suited to their current space and expand it as seating needs grow, without replacing the original investment. Each added module integrates with existing components from the same design system, maintaining the visual and structural coherence of the original arrangement. Two seat insert options are available across all configurations: the Deluxe+ Blend, using layered high-resilience foam for a sink-in feel, and the Memorix+ Blend, using contoured memory foam for a balance of support and cushioning. Configurations begin at $699 through Anabei’s direct-to-consumer model, which removes retail intermediary costs from the purchase price.

Anabei operates across the United States, serving families, pet owners, and design-conscious homeowners through a direct-to-consumer model that supports configuration customization and efficient delivery.

About Anabei

Anabei is a U.S.-based direct-to-consumer furniture brand specializing in machine-washable, modular, and sustainably constructed home seating. Developed under parent company CABA Design, whose brand portfolio also includes Diorama and Chicory, Anabei designs furniture for modern households that require performance, adaptability, and ease of maintenance in the same product. The brand’s Oeko-Tex certified, PFC-free performance fabrics and powder-coated steel frames are standard across the full modular line. For configuration options and product details, visit Anabei’s official website.

Media Contact

Organization: Anabei

Contact Person: Anabei

Website: https://anabei.com/

Email: Send Email

Country: United States

Release id: 49936

View source version on King Newswire:
Anabei Addresses Furniture Reviews With Machine-Washable System for Families

file

About Author

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST